Stockscreener 앱 받기
0.8698
0.00%
0.00
전일 마감가:
$0.8698
열려 있는:
$0.85
하루 거래량:
32,475
Relative Volume:
0.16
시가총액:
$26.84M
수익:
$2.82M
순이익/손실:
$-13.47M
주가수익비율:
-1.279
EPS:
-0.68
순현금흐름:
$-13.61M
1주 성능:
-1.16%
1개월 성능:
-22.00%
6개월 성능:
-10.34%
1년 성능:
-29.29%
1일 변동 폭
$0.85
$0.92
1주일 범위
$0.85
$0.92
52주 변동 폭
$0.551
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
NMTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1858 | 380.07M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.61 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.38 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.405 | 161.48M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
10.78 | 123.51M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
NeuroOne CEO shares company strategy in letter to shareholders - Investing.com
NeuroOne faces Nasdaq delisting over share price issue By Investing.com - Investing.com Australia
NeuroOne Medical Technologies Faces Delisting from Nasdaq Due to Non-Compliance - Defense World
NeuroOne faces Nasdaq delisting over share price issue - Investing.com India
NeuroOne Reports Record Revenue Boost in Q1 2025 - Yahoo Finance
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - Stock Titan
NeuroOne Medical Projects 190% Revenue Growth, Expands Zimmer Biomet Partnership - Stock Titan
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11: 00 a.m. EST - Marketscreener.com
NeuroOne Medical Projects 190% Revenue Growth, Sets Investor Webinar to Showcase Expansion - Stock Titan
NeuroOne Medical Technologies Reports Increased Product Revenue and Strategic Partnerships in 2024 - Defense World
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation - Investing.com Australia
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation By Investing.com - Investing.com South Africa
NeuroOne Medical Technologies Corp Reports Q4 Net Loss of $3.3 M - GuruFocus.com
NeuroOne Medical Projects 190% Revenue Growth for 2025 After Record-Breaking Year - StockTitan
Neuroone stock hits 52-week low at $0.56 amid market challenges - Investing.com
NeuroOne Medical Technologies Sets Q4 2024 Earnings Release Date - StockTitan
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - The Globe and Mail
Nashville InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
Neuroone stock hits 52-week low at $0.59 amid market challenges - Investing.com
AWM Investment Company, Inc. Increases Stake in NeuroOne Medical Technologies Corp - GuruFocus.com
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event - Yahoo Finance
NeuroOne ends loan agreement with Growth Opportunity Funding - Investing.com
Zimmer Biomet to Present at Jefferies London Healthcare Conference - Marketscreener.com
NeuroOne agree $3m partnership with Zimmer Biomet - Yahoo! Voices
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation system - NeuroNews International
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Expands with NeuroOne Alliance and Z1 Hip System Launch - Yahoo Finance
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neuroone Medical Technologies Corp 주식 (NMTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director |
Jun 06 '24 |
Sale |
0.88 |
2,189 |
1,918 |
295,035 |
| Christianson Mark | Business Development Director |
Jun 05 '24 |
Sale |
0.88 |
25,800 |
22,663 |
297,224 |
0.44%
0.15%
자본화:
|
볼륨(24시간):